Allogeneic CD56 + cell infusion as a bridge to hematopoietic stem cell transplantation in relapsed/refractory acute myeloid leukemia: a phase I clinical trial. - Ghasabeh AS; Izadpanah A; Bakhtiyaridovvombaygi M; Seresht-Ahmadi M; Parkhideh S; Seraji HR; Sabri A; Yazdanparast S; Hajifathali A; Gharehbaghian A; Roshandel E (Cancer immunology, immunotherapy : CII, 2026)